[Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].Pathol Biol (Paris). 1985 Jun; 33(5 Pt 2):607-10.PB
Abstract
Treatment of visceral and cutaneous leishmaniasis rests on pentavalent antimonial drugs. However, side effects are often a problem and resistance may emerge. N-methyl-glucamine given for kala-azar induced hematologic or hepatic toxicity in three patients and failed in two. Four patients with cutaneous leishmaniasis recovered but two exhibited adverse side effects. Sodium stibo-gluconate failed in one of three kala-azar patients and in one of two patients with cutaneous leishmaniasis. The effects of these two drugs are discussed, as well as indications of pentamidine and splenectomy.
MeSH
Pub Type(s)
Journal Article
Language
fre
PubMed ID
3003657
Citation
Bourée, P, et al. "[Methylglucamine Antimoniate and Sodium Stibogluconate in the Treatment of Leishmaniasis. Study of 16 Cases]." Pathologie-biologie, vol. 33, no. 5 Pt 2, 1985, pp. 607-10.
Bourée P, Anciaux ML, Taugourdeau P. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases]. Pathol Biol (Paris). 1985;33(5 Pt 2):607-10.
Bourée, P., Anciaux, M. L., & Taugourdeau, P. (1985). [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases]. Pathologie-biologie, 33(5 Pt 2), 607-10.
Bourée P, Anciaux ML, Taugourdeau P. [Methylglucamine Antimoniate and Sodium Stibogluconate in the Treatment of Leishmaniasis. Study of 16 Cases]. Pathol Biol (Paris). 1985;33(5 Pt 2):607-10. PubMed PMID: 3003657.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
AU - Bourée,P,
AU - Anciaux,M L,
AU - Taugourdeau,P,
PY - 1985/6/1/pubmed
PY - 1985/6/1/medline
PY - 1985/6/1/entrez
SP - 607
EP - 10
JF - Pathologie-biologie
JO - Pathol Biol (Paris)
VL - 33
IS - 5 Pt 2
N2 - Treatment of visceral and cutaneous leishmaniasis rests on pentavalent antimonial drugs. However, side effects are often a problem and resistance may emerge. N-methyl-glucamine given for kala-azar induced hematologic or hepatic toxicity in three patients and failed in two. Four patients with cutaneous leishmaniasis recovered but two exhibited adverse side effects. Sodium stibo-gluconate failed in one of three kala-azar patients and in one of two patients with cutaneous leishmaniasis. The effects of these two drugs are discussed, as well as indications of pentamidine and splenectomy.
SN - 0369-8114
UR - https://www.unboundmedicine.com/medline/citation/3003657/[Methylglucamine_antimoniate_and_sodium_stibogluconate_in_the_treatment_of_leishmaniasis__Study_of_16_cases]_
DB - PRIME
DP - Unbound Medicine
ER -